E

ELEVAI Labs Inc
NASDAQ:ELAB

Watchlist Manager
ELEVAI Labs Inc
NASDAQ:ELAB
Watchlist
Price: 3.28 USD 3.14% Market Closed
Market Cap: 2.4m USD

Gross Margin

27.3%
Current
Declining
by 41.5%
vs 3-y average of 68.8%

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
27.3%
=
Gross Profit
$78k
/
Revenue
$286k

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
27.3%
=
Gross Profit
$78k
/
Revenue
$286k

Peer Comparison

Country Company Market Cap Gross
Margin
US
ELEVAI Labs Inc
NASDAQ:ELAB
2.4m USD
Loading...
US
Kenvue Inc
NYSE:KVUE
33B USD
Loading...
BR
Natura &Co Holding SA
OTC:NTCOY
7.7B USD
Loading...
KR
APR Co Ltd
KRX:278470
9.2T KRW
Loading...
CN
Mao Geping Cosmetics Co Ltd
HKEX:1318
42.3B HKD
Loading...
KY
Herbalife Ltd
XMUN:HOO
4.7B EUR
Loading...
IL
Oddity Tech Ltd
NASDAQ:ODD
2B USD
Loading...
CN
Runben Biotechnology Co Ltd
SSE:603193
10.1B CNY
Loading...
KR
d'Alba Global Co Ltd
KRX:483650
1.8T KRW
Loading...
IN
Honasa Consumer Ltd
NSE:HONASA
91.4B INR
Loading...
CN
Dencare Chongqing Oral Care Co Ltd
SZSE:001328
7B CNY
Loading...
No Stocks Found

Market Distribution

Lower than 72% of companies in the United States of America
Percentile
28th
Based on 12 729 companies
28th percentile
27.3%
Low
-24 813% — 28.9%
Typical Range
28.9% — 60.5%
High
60.5% — 10 905 714.3%
Distribution Statistics
the United States of America
Min -24 813%
30th Percentile 28.9%
Median 43%
70th Percentile 60.5%
Max 10 905 714.3%

ELEVAI Labs Inc
Glance View

Market Cap
2.4m USD
Industry
Consumer products

ELEVAI Labs Inc is a US-based company operating in Personal Care Products industry. The company is headquartered in Newport Beach, California. The company went IPO on 2023-11-21. Elevai Labs, Inc. is a physician-dispensed skincare company. The firm conducts research and development to advance science-driven topical skincare that complements the medical aesthetics industry. The company produces and commercializes topical skincare products that contain its proprietary stem cell derived Elevai Exosomes designed to enhance the appearance of skin. Its Precision Regenerative Exosome Technology (PREx) biotechnology process yields exosome lots from human umbilical cord-derived mesenchymal stem cells (hUMSC) for its specialty physician-dispensed skincare products. The company has integrated the use of stem cell exosomes into its initial product line: Elevai Post Treatment E-Series. The E-Series comprises two post-skincare procedure care products that target the face and neck, and upper chest regions. Its products include Empower and Enfinity serums. Empower is its after-treatment topical product that supports the appearance of healthy skin and promotes an even toned complexion.

ELAB Intrinsic Value
Not Available
What is Gross Margin?
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
How is Gross Margin calculated?

Gross Margin is calculated by dividing the Gross Profit by the Revenue.

Gross Margin
27.3%
=
Gross Profit
$78k
/
Revenue
$286k
What is ELEVAI Labs Inc's current Gross Margin?

The current Gross Margin for ELEVAI Labs Inc is 27.3%, which is below its 3-year median of 68.8%.

How has Gross Margin changed over time?

Over the last 2 years, ELEVAI Labs Inc’s Gross Margin has decreased from 67.4% to 27.3%. During this period, it reached a low of 27.3% on Oct 30, 2025 and a high of 94.6% on Sep 30, 2024.

Back to Top